01 Jan 2021

Future Unicorn Award nominee: Oncomfort

Future Unicorn Award 2021

Oncomfort commercializes Digital Sedation, a digital therapy to reduce pain and anxiety in patients.

Oncomfort disrupts healthcare practice: what the electrical car is for the car industry, Oncomfort Digital Sedation is for the acute and potentially even chronic healthcare industry worldwide. It is a safe and effective digital therapy to manage patients’ pain and anxiety before, during and after medical procedures, without medication. Better patient care with significantly less side effects and better outcome are key in elements in healthcare. Oncomfort answers a global need, is scalable and flexible and has a strong intellectual property.

What is the one thing you owe your success to?

“The one thing we owe our success to is the co-creative effort with clinicians, academics, psychologists and engineers clearly convinced of the non-pharmacological digital therapy capabilities as a novel standard for better healthcare.”

Oncomfort

To learn more about Oncomfort, visit their website

About the Future Unicorn Award

  • The Future Unicorn Award aims to highlight innovative start-ups and scale-ups that have the potential to become Europe’s next unicorns. The award is compiled by asking all the national trade associations affiliated with DIGITALEUROPE to nominate a single SME from their country. This results in a truly pan-European selection of incredible digital companies from all sectors.

    The award will be delivered at our flagship event, Masters of Digital on 4 February.

05 Jul 2024 resource
The Download: Closing the digital skills gap
02 Jul 2024 resource
Overcoming Europe’s connectivity challenges to reclaim global leadership
19 Jun 2024 Publication & Brochure
The EU's Critical Tech Gap: Rethinking economic security to put Europe back on the map
Hit enter to search or ESC to close
This website uses cookies
We use cookies and similar techonologies to adjust your preferences, analyze traffic and measure the effectiveness of campaigns. You consent to the use of our cookies by continuing to browse this website.
Decline
Accept